Northern Trust Corp Essa Pharma Inc. Transaction History

Northern Trust Corp

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	BUY	$2.56 - $3.55 $1,948 - $2,701	761 Added 6.49%	12,489 $37,000
Q4 2022 Feb 13, 2023	SELL	$1.5 - $4.82 $210 - $674	-140 Reduced 1.18%	11,728 $29,000
Q3 2022 Nov 14, 2022	BUY	$1.75 - $3.44 $348 - $684	199 Added 1.71%	11,868 $22,000
Q2 2022 Aug 12, 2022	SELL	$3.15 - $7.94 $41,816 - $105,403	-13,275 Reduced 53.22%	11,669 $37,000
Q1 2022 May 13, 2022	SELL	$6.18 - $14.44 $3,800 - $8,880	-615 Reduced 2.41%	24,944 $154,000
Q4 2021 Feb 08, 2022	BUY	$7.8 - $14.38 $31,995 - $58,986	4,102 Added 19.12%	25,559 $363,000
Q3 2021 Nov 15, 2021	SELL	$7.76 - $29.37 $58,200 - $220,275	-7,500 Reduced 25.9%	21,457 $172,000
Q2 2021 Aug 13, 2021	BUY	$24.17 - $34.28 $408,569 - $579,469	16,904 Added 140.25%	28,957 $827,000
Q1 2021 May 12, 2021	BUY	$11.61 - $32.08 $139,935 - $386,660	12,053 New	12,053 $350,000

35.1M

15.8K

21K

Ticker EPIX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 44,073,100
Market Cap $72.3M
Description
ESSA Pharma Inc., a clinical stage pharmaceutical company, focuses on developing novel and proprietary therapies for the treatment of prostate cancer. It develops EPI-7386, an oral candidate that is in a Phase I clinical study for the treatment of patients with metastatic castration-resistant prostate cancer. The company has collaboration agreem...

Get notified when there are updates to the investment portfolio of Northern Trust Corp, based on Form 13F filings with the SEC.

Stay updated on Northern Trust Corp with notifications on news.